J&J, Merck, Boston Scientific Debut Trio Of Splashy Takeovers Topping $3 Billion In Value

Johnson & Johnson (JNJ), Merck (MRK), and Boston Scientific (BSX) made significant acquisitions totaling over $3 billion at a major medical conference. J&J purchased Ambrx (AMAM) for $2 billion, while Merck acquired Harpoon Therapeutics (HARP) for $680 million. Boston Scientific is buying Axonics (AXNX) for $3.7 billion, and Novartis is acquiring Calypso Biotech for $250 million. These deals involve companies specializing in areas such as cancer treatment, autoimmune diseases, and medtech devices. The stocks of AMAM and HARP surged in premarket trading, while J&J, Merck, and Boston Scientific saw modest changes.